Histamine and antipsychotic drug-induced weight gain

Journal of Psychopharmacology

Volumn 26, Issue 12, 2012, Pages 1608-1609

  Reynolds, Gavin P ^a  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETAHISTINE; CLOZAPINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H3 RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LORCASERIN; NEUROLEPTIC AGENT; NEUROTRANSMITTER; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN; SEROTONIN 2C ANTAGONIST;

DRUG ACTIVITY; DRUG APPROVAL; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG INDUCED WEIGHT GAIN; DRUG MECHANISM; DRUG METABOLISM; ENZYME ACTIVATION; EVIDENCE BASED MEDICINE; FOOD INTAKE; INVERSE AGONISM; LETTER; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SYNAPTIC TRANSMISSION; WEIGHT GAIN;

ANIMALS; ANTIPSYCHOTIC AGENTS; APPETITE DEPRESSANTS; BENZODIAZEPINES; BETAHISTINE; DISEASE MODELS, ANIMAL; FEMALE; HYPERPHAGIA; WEIGHT GAIN;

EID: 84870468927     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881112463127     Document Type: Letter

References (12)

1. Consensus development conference on antipsychotic drugs and obesity and diabetes. J Clin Psychiatry. 2004 ; 65: 267-272
2. Arrang JM, Garbarg M, Quach TT, et al. Actions of betahistine at histamine receptors in the brain. Eur J Pharmacol. 1985 ; 111: 73-84
3. Deng C, Lian J, Pai N, et al. Reducing olanzapine-induced weight gain side effect by using betahistine: A study in the rat model. J Psychopharmacol. 2012 ; 26: 1271-1279
4. Ferno J, Varela L, Skrede S, et al. Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation. PLoS One. 2011 ; 6: e20571
5. Gbahou F, Davenas E, Morisset S, et al. Effects of betahistine at histamine H3 receptors: Mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo. J Pharmacol Exp Ther. 2010 ; 334: 945-954
6. Goudie AJ, Halford JC, Dovey TM, et al. H(1)-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology. 2003 ; 28: 2209
7. Kim SF, Huang AS, Snowman AM, et al. From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase. Proc Natl Acad Sci U S A. 2007 ; 104: 3456-3459
8. Kirk SL, Glazebrook J, Grayson B, et al. Olanzapine-induced weight gain in the rat: Role of 5-HT2C and histamine H1 receptors. Psychopharmacology (Berl). 2009 ; 207: 119-125
9. Kroeze WK, Hufeisen SJ, Popadak BA, et al. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology. 2003 ; 28: 519-526
10. Matsui-Sakata A, Ohtani H, Sawada Y. Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus. Drug Metab Pharmacokinet. 2005 ; 20: 368-378
11. Pillot C, Heron A, Cochois V, et al. A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain. Neuroscience. 2002 ; 114: 173-193
12. Reynolds GP, Kirk SL. Metabolic side effects of antipsychotic drug treatment - pharmacological mechanisms. Pharmacol Ther. 2010 ; 125: 169-179